Research Article

A Comparison Study of Antiultraviolet and Sustained Release Properties of Polydopamine/Avermectin Microcapsule and Microsphere

Table 4

Fitting results for release curves of AVM/PDAMS and AVM@PDAMC.

Release modelpHAVM@PDAMCAVM/PDAMS
K1K2K3R2K1K2K3R2

Zero-order model30.00420.96350.00530.7433
70.00240.91480.00350.8898
90.00310.89180.00400.8734
First-order model30.02270.68570.86670.06390.88700.9279
70.04850.39530.74290.04980.57260.7971
90.04550.49320.83210.04380.63070.8765
Hixson–Crowell model30.00230.59630.90270.00200.75930.6685
70.00160.56620.85860.00180.64130.8275
90.00180.59940.82970.00200.64300.8064
Weibull model315.76610.57270.95386.29090.59220.9951
710.81110.37100.98257.86660.41690.9861
910.09340.41990.98869.13890.47990.9930
Higuchi model30.06060.96660.10050.7808
70.04320.82590.06270.8367
90.05300.88130.06710.9119
Baker–Lonsdale model38.7246 × 10−40.99350.00300.9811
73.4348 × 10−40.98408.2042 × 10−40.9866
95.5707 × 10−40.98710.00100.9919
Korsmeyer–Peppas model30.43920.07850.97500.30720.22690.9717
70.31540.09410.98980.31840.13500.9950
90.33800.10510.99380.35390.12470.9967
Quadratic model3−4.5900 × 10−71.1162 × 10−40.8162−1.1684 × 10−62.2483 × 10−40.5998
7−4.1335 × 10−78.7622 × 10−50.4807−6.2282 × 10−71.2960 × 10−40.5316
9−5.0533 × 10−71.0750 × 10−40.6004−6.4022 × 10−71.3630 × 10−40.6741
Logistic model338.00520.03290.70660.993413.45920.07720.90550.9679
722.04110.03540.44400.969319.57880.04190.62220.9699
920.96080.04300.52870.959421.33790.04670.66530.9502